|
UBE2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.029260E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.355800E-04 |
| Normal-vs-Stage2 |
2.36119999996731E-06 |
| Normal-vs-Stage3 |
4.809000E-04 |
| Normal-vs-Stage4 |
1.218370E-04 |
| Stage1-vs-Stage2 |
1.768100E-02 |
| Stage1-vs-Stage3 |
8.786200E-01 |
| Stage1-vs-Stage4 |
2.822800E-01 |
| Stage2-vs-Stage3 |
3.575700E-02 |
| Stage2-vs-Stage4 |
2.666000E-01 |
| Stage3-vs-Stage4 |
3.723000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.816940E-04 |
| Normal-vs-AfricanAmerican |
1.344400E-02 |
| Normal-vs-Asian |
7.461200E-03 |
| Caucasian-vs-AfricanAmerican |
5.529800E-01 |
| Caucasian-vs-Asian |
3.958200E-01 |
| AfricanAmerican-vs-Asian |
9.662600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.426300E-04 |
| Normal-vs-Female |
1.203420E-04 |
| Male-vs-Female |
9.406800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.677400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.18940000000068E-05 |
| Normal-vs-Age(61-80Yrs) |
1.29240000001918E-06 |
| Normal-vs-Age(81-100Yrs) |
2.707800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.842400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.324750E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.120600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.278850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.103900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.514600E-01 |
| Classical-VS-Follicular |
4.37420000221067E-09 |
| Classical-VS-Other |
6.975800E-01 |
| Classical-VS-Normal |
2.576000E-03 |
| Tall-VS-Follicular |
6.351400E-04 |
| Tall-VS-Other |
6.806600E-01 |
| Tall-VS-Normal |
2.457600E-02 |
| Follicular-VS-Other |
1.445380E-01 |
| Follicular-VS-Normal |
2.69000000052699E-08 |
| Other-VS-Normal |
1.483800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27639999994533E-06 |
| Normal-vs-N1 |
3.019400E-03 |
| N0-vs-N1 |
7.416300E-02 |
|
|
